NCT Number: NCT04428788
Phase: Phase 1
Trial Summary: The purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate canc – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Celgene
Acronym:
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives